Study period | Screening | Study treatment | Treatment completion | Post treatment | |
---|---|---|---|---|---|
Day/month/year | −28 to 0 days | Clinical visit | Any time | 2nd year | 3rd–5th years |
Informed consent | X | ||||
Medical history | X | ||||
Demography | X | ||||
Pregnancy test, if appropriate | X | ||||
Physical examination, ECOG, vital signs | X | Xa | X | ||
Hematology | X | Xa | X | ||
Biochemistry | X | Xa | X | ||
CT or MRIb | X | X | X | ||
Abdominal echoc | Xc | Every 6 months | Every 6 months | ||
Carcinoembryonic antigen (CEA) | X | Xa | X | Every 3 months | Every 6 months |
Study treatmentd | X | ||||
Adverse events | X | Xe |